JPH01238532A - Antiinfectant - Google Patents
AntiinfectantInfo
- Publication number
- JPH01238532A JPH01238532A JP63062755A JP6275588A JPH01238532A JP H01238532 A JPH01238532 A JP H01238532A JP 63062755 A JP63062755 A JP 63062755A JP 6275588 A JP6275588 A JP 6275588A JP H01238532 A JPH01238532 A JP H01238532A
- Authority
- JP
- Japan
- Prior art keywords
- powder
- pine tree
- alkaline water
- extract
- shells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims abstract description 27
- 235000011613 Pinus brutia Nutrition 0.000 claims abstract description 27
- 241000018646 Pinus brutia Species 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000000284 extract Substances 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 5
- 229960005475 antiinfective agent Drugs 0.000 claims description 7
- 239000004599 antimicrobial Substances 0.000 claims description 7
- 235000005205 Pinus Nutrition 0.000 claims 1
- 241000218602 Pinus <genus> Species 0.000 claims 1
- 239000000843 powder Substances 0.000 abstract description 18
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 abstract description 8
- 235000011114 ammonium hydroxide Nutrition 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 238000002347 injection Methods 0.000 abstract description 6
- 239000007924 injection Substances 0.000 abstract description 6
- 230000003612 virological effect Effects 0.000 abstract description 6
- 230000002924 anti-infective effect Effects 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 5
- 238000000605 extraction Methods 0.000 abstract description 4
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 235000005638 Austrian pine Nutrition 0.000 abstract description 2
- 235000018782 Dacrydium cupressinum Nutrition 0.000 abstract description 2
- 235000008565 Pinus banksiana Nutrition 0.000 abstract description 2
- 244000019397 Pinus jeffreyi Species 0.000 abstract description 2
- 235000013264 Pinus jeffreyi Nutrition 0.000 abstract description 2
- 235000013697 Pinus resinosa Nutrition 0.000 abstract description 2
- 235000008578 Pinus strobus Nutrition 0.000 abstract description 2
- 235000008585 Pinus thunbergii Nutrition 0.000 abstract description 2
- 235000014030 Podocarpus spicatus Nutrition 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract description 2
- 239000008187 granular material Substances 0.000 abstract description 2
- 235000017985 rocky mountain lodgepole pine Nutrition 0.000 abstract description 2
- 241001236215 Pinus parviflora Species 0.000 abstract 2
- 206010067482 No adverse event Diseases 0.000 abstract 1
- 241000534656 Pinus resinosa Species 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 238000007796 conventional method Methods 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- 241000282326 Felis catus Species 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010060891 General symptom Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000003200 peritoneal cavity Anatomy 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 235000007756 Akebia quinata Nutrition 0.000 description 1
- 240000008027 Akebia quinata Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 240000006055 Dacrydium cupressinum Species 0.000 description 1
- 206010061126 Escherichia infection Diseases 0.000 description 1
- 208000002613 Feline Panleukopenia Diseases 0.000 description 1
- 241000701915 Feline panleukopenia virus Species 0.000 description 1
- 201000008808 Fibrosarcoma Diseases 0.000 description 1
- 208000005232 Glossitis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000125945 Protoparvovirus Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 208000020612 escherichia coli infection Diseases 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 108010001062 polysaccharide-K Proteins 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、植物性物質より得られる抗感染症剤に関する
。DETAILED DESCRIPTION OF THE INVENTION (Industrial Field of Application) The present invention relates to an anti-infective agent obtained from botanical substances.
(従来の技術)
現在、抗感染症剤として種々の化合物か提案され、医薬
品として開発されているか、効果、副作用等の点から決
定的なものは得られていない。ところて、これらの抗感
染症剤の中には、クレスチンのように植物成分から開発
されたものかある。このことから、本発明者らは種々の
植物成分の抗感染症作用について鋭意検討を重ねた結果
、松の実の殻からアルカリ水によって抽出される抽出物
か有効な抗感染症作用を有することを見出した。(Prior Art) At present, various compounds have been proposed as anti-infective agents, and none have been developed as pharmaceuticals, and nothing definitive has been obtained in terms of effectiveness, side effects, etc. By the way, some of these anti-infective agents, such as Krestin, were developed from plant ingredients. Based on this, the present inventors have conducted intensive studies on the anti-infective effects of various plant components, and have found that the extract extracted from pine nut shells with alkaline water has an effective anti-infective effect. I found out.
(発明の構成)
本発明は、有効成分として、五葉松(Pinuspar
viflora 5ieb、 et Zucc、)等の
松の実の殻のアルカリ水抽出物を含有することを特徴と
する抗感染症剤に関する。(Structure of the Invention) The present invention uses Pinuspar as an active ingredient.
The present invention relates to an anti-infective agent containing an alkaline aqueous extract of pine nut shells such as Viflora 5ieb, et Zucc, etc.
松の実には、黒松、赤松、五葉松等の種々の松の松の実
があるか、本発明にはいづれの松の実も使用できる。し
かしながら、食用となる松の実を産する五葉松のものか
特に好ましい。There are various types of pine nuts, such as black pine, red pine, and five-leaf pine, and any pine nuts can be used in the present invention. However, it is particularly preferable to use Goyo-pine, which produces edible pine nuts.
本発明に用いる松の実は、その採取時期は特に限定され
ないが、成分か豊富に含まれていると考えられる11月
中旬頃のものか好ましい。The harvesting time of the pine nuts used in the present invention is not particularly limited, but it is preferable to pick them around mid-November as they are considered to be rich in components.
松の実の殻は、松かさから松の実を分離し。Pine nut shell separates pine nuts from pine cones.
実の外面を覆う殻を採取する。殻は、必要に応して適当
に乾燥し、抽出に適する粒度に粉砕するとよい。Collect the shell that covers the outside of the fruit. The shells may be dried appropriately if necessary and ground to a particle size suitable for extraction.
成分を抽出するためのアルカリ水としては、有機塩基、
無機塩基のいづれによるアルカリ水てあってもよい。し
かしながら、抽出液や抽出物のその後の処理及び調剤な
どの点からアンモニア水などのように、加熱等によって
容易にアルカリ分を除けるものか好ましい。As alkaline water for extracting components, organic bases,
Alkaline water with any inorganic base may be used. However, from the viewpoint of subsequent processing and preparation of the extract and the extract, it is preferable to use a solution such as aqueous ammonia whose alkali content can be easily removed by heating or the like.
アルカリ水のアルカリ度(all)は松の実の種類や量
によって異なるか、9117以上てあればよく、好まし
くはall7.5〜IO程度である。The alkalinity (ALL) of the alkaline water may vary depending on the type and amount of pine nuts, or may be 9117 or higher, preferably about 7.5 to IO.
抽出は、適当な大きさに粉砕した松の実の殻をアルカリ
水に浸漬することによって行う。Extraction is carried out by soaking pine nut shells crushed into appropriate sizes in alkaline water.
抽出に使用するアルカリ水の量は、特に限定されないか
、松の実の殻の量の5倍程度の容量を使用するとよい。The amount of alkaline water used for extraction is not particularly limited, or may be about 5 times the amount of pine nut shells.
アルカリ水の温度は常温でもよいか、加温してもよい。The temperature of the alkaline water may be at room temperature or may be heated.
抽出液は、濾過等の手段により松の実の殻と分離し、減
圧濃縮等の手段によって適当な濃度に濃縮した後、塩酸
等の適当な酸で中性ないし微酸性に調整し、その後凍結
乾燥や風乾などの方法により乾燥して、粉末として目的
物を得る。The extract is separated from the pine nut shells by means such as filtration, concentrated to an appropriate concentration by means such as vacuum concentration, adjusted to neutral or slightly acidic with an appropriate acid such as hydrochloric acid, and then frozen. Dry by drying or air drying to obtain the desired product as a powder.
得られた粉末は、わずかに特有のにおいを有する、水に
易溶の褐色の粉末である。The resulting powder is a brown powder, easily soluble in water, with a slightly characteristic odor.
本発明の有効成分は、薬剤調製上許容される固体または
液体の適当な担体とともに、錠剤、顆粒剤、粉剤等の固
形剤、または注射液等の液剤に調剤することかできる。The active ingredient of the present invention can be formulated into a solid preparation such as a tablet, granule, or powder, or a liquid preparation such as an injection solution, together with a suitable solid or liquid carrier acceptable for drug preparation.
(実施例および試験例)
以下に本発明の一実施例を示すか、本発明はこれに限定
されるものではない。(Example and Test Example) An example of the present invention will be shown below, but the present invention is not limited thereto.
一距、の
五葉松の松の実(11月中旬に中国、吉林省庫江市て採
集したもの)から、先に発明者の一人か提案した方法(
特開昭61−171551号)で松の実の殻を得る。A method previously proposed by one of the inventors (
(Japanese Patent Application Laid-Open No. 171551/1983) to obtain pine nut shells.
得られた松の実の殻1kgに、0.8%アンモニア水6
文を加え、45°Cにて3時間攪拌して抽出した。抽出
液を分離した後、残渣をもう一度同様にしてアンモニア
水抽出を行い、抽出液を合わせ、濾布で濾過した。濾液
(9,5文)を40°Cて1501にまで減圧濃縮し、
塩酸でpi 5.4に調整し凍結乾燥して、褐色の粉末
45gを得た。0.8% ammonia water 6 to 1 kg of obtained pine nut shells
The mixture was extracted by stirring at 45°C for 3 hours. After separating the extract, the residue was extracted with aqueous ammonia in the same manner once again, and the extracts were combined and filtered through a filter cloth. The filtrate (9.5 sentences) was concentrated under reduced pressure at 40°C to a concentration of 1501.
The pi was adjusted to 5.4 with hydrochloric acid and freeze-dried to obtain 45 g of brown powder.
得られたこの粉末は、わずかに特有のにおいを有し、
ソノ1% (W/V )水溶液ノpHは4.5〜6.0
てあった。粉末1g中のヒ素及び重金属の含量は、それ
ぞれ2pp(30pp■以下であった。This powder obtained has a slightly characteristic odor,
Sono 1% (W/V) aqueous solution pH is 4.5-6.0
There was. The content of arsenic and heavy metals in 1 g of powder was 2 pp (less than 30 pp), respectively.
大腸菌群は陰性で、一般細菌数もt000/g以下てあ
った。Coliform bacteria was negative, and the general bacterial count was less than t000/g.
注射用アンプルの作製は以下の如く行った。An ampoule for injection was prepared as follows.
即ち、得られた粉末10gを約851の水に加え、50
〜60°Cの温度にて30分間攪拌し、溶解した。その
溶解液に食塩0.7gおよび水を加え。That is, add 10 g of the obtained powder to about 851 g of water, and add 50 g of the powder.
Stir for 30 minutes at a temperature of ~60°C to dissolve. Add 0.7 g of common salt and water to the solution.
全量を1001とした。この液を10000rp■、2
0分間の遠心分離により不溶物を除去して、オートクレ
ーブによる高圧滅菌後、無菌的にアンプルに充填したも
のを注射液とした。The total amount was set to 1001. Rinse this liquid at 10,000 rp■, 2
Insoluble matter was removed by centrifugation for 0 minutes, and after high-pressure sterilization in an autoclave, the mixture was aseptically filled into ampoules to obtain an injection solution.
1 )の 球゛ の・ 。1) of the ball.
(1)大I′!SViの感染に対する効果試験0.25
目1gの粉末あるいは生理食塩水(対照)をddyマウ
ス(5退的、雄)各群10〜12匹の腹腔に1回投与後
、20目に大腸菌約4xlO6個を腹腔に移植して、2
4時間目の生存マウス数を算定する。(1) Big I'! Effect test on SVi infection 0.25
After administering 1 g of powder or saline (control) once into the peritoneal cavity of each group of 10 to 12 ddy mice (5 degenerates, male), on the 20th day, approximately 4xlO6 E. coli bacteria were transplanted into the peritoneal cavity.
The number of surviving mice at 4 hours is calculated.
(2)ウィルス性感染症に対する効果試験種々のウィル
ス性疾患に った猫の大腿部に筋肉内投与、あるいは背
中の肩 骨の中間に、指示された回数、前記注射液を1
0■g/ kg投与し、経時的に一般状懲と血液中の白
血球数を測定した。(2) Efficacy test against viral infections The above injection solution was administered intramuscularly to the thigh of cats suffering from various viral diseases, or between the shoulder bones on the back, as many times as instructed.
0 g/kg was administered, and the general symptoms and the number of white blood cells in the blood were measured over time.
(作用)
上記の方法により得た、松の実の殻のアンモニア水抽出
物(粉末及び注射液)の抗感染症作用を、マウスへの大
腸菌の感染阻止活性およびウィルス性疾患に った猫に
対する症状の緩和を指標にして調べた。(Action) The anti-infective activity of the aqueous ammonia extract of pine nut shells (powder and injection solution) obtained by the above method was shown to be effective in inhibiting E. coli infection in mice and in cats with viral diseases. The study was conducted using symptom relief as an indicator.
(1)大腸菌の感染に対する効果
表−工に示される様に、マウス腹腔にあらかじめアンモ
ニア水抽出物(粉末を生理食塩水に溶かしたもの)を前
処理しておくと、マウスに対する大腸菌の感染か有意に
抑制された。(1) Effect on E. coli infection Table - As shown in Figure 4, pre-treatment of mouse abdominal cavity with aqueous ammonia extract (powder dissolved in physiological saline) prevents E. coli infection in mice. significantly suppressed.
表−I 松の実の殻のアンモニア水抽出物(粉末)の大
腸菌感染防御効果
投与剤 投与後5日目の生存マウス数
松の実の殻
アルカリ水抽出II A 7/10(70X)
B S/10 (5(H)
生理食塩水(対照) 1/12 (8%)(2
)ウィルス性感染症に対する効果
衣−Hに示される様に、松の実の殻のアンモニア水抽出
物を注射液として、背中の肩 骨付近に皮下注射あるい
は、大n部に筋肉内注射することにより猫及び犬のウィ
ルス性疾患(カリシウィルス性舌炎、口内炎、歯肉炎、
パルボウイルス性猫汎白血球減少症、ヘルペスウィルス
性鼻気管支炎)に著効を示し1食欲も増進し、一般症状
も改善し、完治した例もあった。これに対して、ウィル
スか原因でない疾患(乳癌、繊維肉腫)には無効であっ
た。Table-I Effect of aqueous ammonia extract of pine nut shell (powder) on preventing Escherichia coli infection Administrative agent Number of surviving mice 5 days after administration Pine nut shell alkaline water extract II A 7/10 (70X)
B S/10 (5(H) Physiological saline (control) 1/12 (8%) (2
) Effective against viral infections - As shown in H, an aqueous ammonia extract of pine nut shells can be injected subcutaneously into the back near the shoulder bone or intramuscularly into the nub. Viral diseases of cats and dogs (caliciviral glossitis, stomatitis, gingivitis,
It was highly effective against parvovirus-induced feline panleukopenia and herpesvirus rhinobronchitis), with appetite improved, general symptoms improved, and complete recovery in some cases. On the other hand, it was ineffective against diseases that were not caused by viruses (breast cancer, fibrosarcoma).
(発明の効果)
本発明の抗感染症剤は、有効な抗感染作用を示し、大腸
菌のマウスへの感染を抑制するばかりてなく、特に動物
(猫、犬)のウィルス性疾患に効果を示すことか判明し
た。このことは松かさ及び松の実の殻のアルカリ水抽出
物か、試験管内てIIIV(human 1m5uno
deficiency virus)のヒトT−細胞へ
の感染(板上ら、エイズ研究会第1回学術集会抄録p6
0.於京都 1978年)及び、インフルエンザウィル
スのMDCK細胞への感染(水田ら、未発表データ)を
10 uLg/■lの濃度で90!抑制するという我々
の知見を確認させるものである。又、本発明の抗感染症
剤は、他の抗ウィルスに見られる様な強い副作用を生し
ることもないので、単独で、または他の治療法もしくは
他の抗ウィルス剤と組合せて使用することにより、より
効果的なウィルス性疾患の治療を行うことかできる。(Effects of the Invention) The anti-infective agent of the present invention exhibits an effective anti-infective effect and not only suppresses E. coli infection in mice, but is also particularly effective against viral diseases in animals (cats, dogs). It turned out that. This has been demonstrated by the alkaline aqueous extract of pine cones and pine nut shells, or by in vitro
infection of human T-cells (Itagami et al., Abstracts of the 1st Annual Meeting of the AIDS Research Society, p. 6)
0. Kyoto, 1978) and influenza virus infection of MDCK cells (Mizuta et al., unpublished data) at a concentration of 10 uLg/■l. This confirms our knowledge that it is suppressed. In addition, the anti-infective agent of the present invention does not cause the strong side effects seen with other anti-viruses, so it can be used alone or in combination with other treatments or other anti-viral agents. More effective treatments for viral diseases can be provided.
Claims (1)
oraSieb.etZucc.)等の松の実の殻のア
ルカリ水抽出物を含有することを特徴とする抗感染症剤
。As an active ingredient, Pinus parvifl
oraSieb. etZucc. An anti-infective agent characterized by containing an alkaline water extract of pine nut shells such as ).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63062755A JP2594453B2 (en) | 1988-03-16 | 1988-03-16 | Anti-infective agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63062755A JP2594453B2 (en) | 1988-03-16 | 1988-03-16 | Anti-infective agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH01238532A true JPH01238532A (en) | 1989-09-22 |
| JP2594453B2 JP2594453B2 (en) | 1997-03-26 |
Family
ID=13209536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63062755A Expired - Fee Related JP2594453B2 (en) | 1988-03-16 | 1988-03-16 | Anti-infective agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2594453B2 (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0573141A2 (en) | 1992-06-04 | 1993-12-08 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Externally-usable hair restorer containing pine extract |
| US5466453A (en) * | 1992-04-02 | 1995-11-14 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Method for improving the taste of pine extract, and orally administrable product obtained thereby |
| WO1997004791A1 (en) * | 1995-07-31 | 1997-02-13 | Mitsui Norin Co., Ltd. | Antiviral agent and process for preparing the same |
| CN1105565C (en) * | 1996-12-27 | 2003-04-16 | 段新华 | Drug for curing dermatosis and preparation method thereof |
| JP2005510490A (en) * | 2001-10-24 | 2005-04-21 | タナカ,アキコ | Anti-HSV drugs for blocking HSV-1 and HSV-2 replication and methods for producing substances having anti-HSV activity |
| US7338676B2 (en) | 2001-09-26 | 2008-03-04 | Tampa Bay Research Institute | Pine cone extracts and uses thereof |
| US7838046B2 (en) | 2001-09-26 | 2010-11-23 | Tampa Bay Research Institute | Plant extracts and uses thereof |
-
1988
- 1988-03-16 JP JP63062755A patent/JP2594453B2/en not_active Expired - Fee Related
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5466453A (en) * | 1992-04-02 | 1995-11-14 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Method for improving the taste of pine extract, and orally administrable product obtained thereby |
| EP0573141A2 (en) | 1992-06-04 | 1993-12-08 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Externally-usable hair restorer containing pine extract |
| WO1997004791A1 (en) * | 1995-07-31 | 1997-02-13 | Mitsui Norin Co., Ltd. | Antiviral agent and process for preparing the same |
| US5929047A (en) * | 1995-07-31 | 1999-07-27 | Mitsui Norin Co., Ltd. | Anti-viral agent prepared by basic and acidic extraction of mangraves |
| CN1105565C (en) * | 1996-12-27 | 2003-04-16 | 段新华 | Drug for curing dermatosis and preparation method thereof |
| US7338676B2 (en) | 2001-09-26 | 2008-03-04 | Tampa Bay Research Institute | Pine cone extracts and uses thereof |
| US7371417B2 (en) * | 2001-09-26 | 2008-05-13 | Tampa Bay Research Institute | Pine cone extracts and uses thereof |
| US7838046B2 (en) | 2001-09-26 | 2010-11-23 | Tampa Bay Research Institute | Plant extracts and uses thereof |
| US7838052B2 (en) | 2001-09-26 | 2010-11-23 | Tampa Bay Research Institute | Pine cone extracts and uses thereof |
| JP2005510490A (en) * | 2001-10-24 | 2005-04-21 | タナカ,アキコ | Anti-HSV drugs for blocking HSV-1 and HSV-2 replication and methods for producing substances having anti-HSV activity |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2594453B2 (en) | 1997-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106668832B (en) | Application of polypeptide in preparation of medicine for treating enterovirus infection | |
| CN102895355B (en) | Chinese medicinal injection for treating livestock diarrhea and preparation method thereof | |
| KR970002643B1 (en) | Method of extracting physiologically active substance from the bark of Songsil and anti-infectious agent whose main ingredient is extract | |
| JP2594453B2 (en) | Anti-infective agent | |
| CN106577480A (en) | Breeding method for improving disease resistance of cattle | |
| JP3740029B2 (en) | Antiviral agent made from Aosa | |
| RU2363483C1 (en) | Way of prevention of secondary immunodeficiency at young stock of cattle | |
| JP3167777B2 (en) | Antiviral, antibacterial and bactericide | |
| JPH08151329A (en) | Antiviral agent, anticancer agent, and method for producing the same | |
| CN1430967A (en) | Naringin used in preparing medicine for curing acute and chronic bronchitis | |
| WO2018132255A1 (en) | Method for treating osteoarthritis | |
| CN109464652B (en) | Composition for livestock diarrhea and preparation method and application thereof | |
| RU2382652C1 (en) | Therapeutic preparation for young growth of agricultural animals and method for prevention and treatment of gastrointestinal diseases of calves with its application | |
| JP4610730B2 (en) | Composition for calcium supplementation | |
| KR20020025433A (en) | Composition And Complex For Enhancing The Biological Function of Animals | |
| CN112586441A (en) | African swine fever prevention and control method and application thereof | |
| RU2423996C1 (en) | Method of phytopreparation therapy of gastrointestinal diseases in calves | |
| CN101559166A (en) | Ophiopogon japonicus extract, preparation method and hypoglycemic application thereof | |
| CN104606627B (en) | A kind of pharmaceutical composition for treating grice diarrhoea and preparation method thereof | |
| RU2371192C1 (en) | Medicine stimulating protective powers of organism, and method of correction of secondary immunodeficiencies with its application | |
| RU2726001C1 (en) | Aquaplant biologically active composition | |
| CN105982918A (en) | Medicine for preventing and treating animal foot-and-mouth disease | |
| JP2004269395A (en) | Composition having a blood pressure lowering effect | |
| CN101152262A (en) | New anti-gout medicinal preparation | |
| CN1141944C (en) | Preparation method of medicine for treating leukemia extracted from scallop visceral mass |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |